Lonnel Coats is CEO & President at LEXICON PHARMACEUTICALS, INC. (LXRX). They have made 12 open-market trades across 2 companies since 2017, most recently 2025-07-17.
CIK 0001612528
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
11 open-market purchases totalling $1.4M since 2017, against 1 sale. Across 11 scored buys the stock is up 34.9% at ninety days, and 29.6 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 27% | 27% | 45% |
| Avg Move | -4.5% | +7.6% | +34.9% |
| Alpha | -5.1% | +4.5% | +29.6% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPMC | SELL · 10b5-1 | 2024-11-20 | 2024-11-22 | $94.46 | $3.3M | +0.7% | -4.3% | -0.1% |
| LXRX | BUY | 2023-11-16 | 2023-11-17 | $1.05 | $95K | -7.8% | +5.2% | +211.3% |
| LXRX | BUY | 2023-11-10 | 2023-11-13 | $1.01 | $10K | +4.6% | +18.5% | +170.4% |
| LXRX | BUY | 2023-06-29 | 2023-06-29 | $2.16 | $22K | +4.1% | -9.5% | -45.5% |
| LXRX | BUY | 2023-06-23 | 2023-06-26 | $2.34 | $47K | +0.5% | -12.2% | -52.0% |
| LXRX | BUY | 2023-06-22 | 2023-06-22 | $2.31 | $92K | -7.0% | -17.7% | -52.3% |
| LXRX | BUY | 2019-09-18 | 2019-09-19 | $3.10 | $155K | -8.9% | -4.9% | +30.3% |
| LXRX | BUY | 2019-09-17 | 2019-09-18 | $3.13 | $283K | -21.0% | -16.0% | +20.7% |
| LXRX | BUY | 2019-08-16 | 2019-08-20 | $1.35 | $59K | -5.7% | +146.4% | +152.1% |
| BPMC | SELL | 2019-08-15 | 2019-08-19 | $82.62 | $1.3M | -2.8% | -1.6% | -7.7% |
| LXRX | BUY | 2017-11-15 | 2017-11-15 | $9.91 | $99K | -0.9% | -0.8% | -9.5% |
| LXRX | BUY | 2017-09-15 | 2017-09-18 | $12.54 | $383K | -3.5% | -12.6% | -21.0% |
| LXRX | BUY | 2017-09-15 | 2017-09-18 | $12.54 | $118K | -3.5% | -12.6% | -21.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.